Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest STAAR Surgical Stories

2014-03-17 08:28:35

First of Kind Product in the U.S. MONROVIA, Calif., March 17, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye and delivery systems reported that its Visian Toric Implantable Lens or TICL received favorable votes to three questions presented to the U.S. Food and Drug Administration's (FDA) Ophthalmic Devices Panel of the Medical Devices Advisory Committee. The Ophthalmic Devices Panel reviews and...

2014-01-30 08:30:06

Appointment Expands Board to Seven Members MONROVIA, Calif., Jan. 30, 2014 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the appointment of Kathryn Tunstall to its Board of Directors. Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a...

2013-11-14 12:27:20

MONROVIA, Calif., Nov. 14, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it is hosting an investor breakfast and webcast on Saturday, November 16 during the American Academy of Ophthalmology (AAO) Annual Meeting in New Orleans, LA. Dr. Erik Mertens, Medical Director and founder of the Medipolis Eye Centre in Antwerp, Belgium, will provide an update on...

2013-11-05 08:33:28

~Stephens Fall Investment Conference on November 13 MONROVIA, Calif., Nov. 5, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it will participate in two upcoming investor conferences to review the Company's recent financial results and business developments with investors and interested parties. Barry Caldwell, President and CEO, and Steve Brown, CFO, will...

2013-10-03 04:20:36

Introduction of the New Visian ICL Preloaded System MONROVIA, Calif., Oct. 3, 2013 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today provided a preview of the activities scheduled prior to and during the 2013 Congress of European Society of Cataract and Refractive Surgeons (ESCRS) to be held in Amsterdam, The Netherlands October 5 - 9, 2013. During the week, STAAR will host...

2013-08-19 08:27:36

~ Growing Number of Approvals for CentraFLOW Technology Driving Increased Adoption of ICL Procedure MONROVIA, Calif., Aug. 19, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it has received regulatory approval to market its Visian® Implantable Collamer® Lens (ICL(TM)) with CentraFLOW(TM) technology from the CDSCO in India. "Following our recent...

2013-07-31 16:28:18

Total Sales of $18.2 Million Increased 14% from Q2 2012 / 20% Increase on Constant Currency Basis MONROVIA, Calif., July 31, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported revenue for the second quarter ended June 28, 2013 of $18.2 million, which represented 14% growth compared to $15.9 million reported for the second quarter of 2012. The...

2013-06-17 08:27:29

~ CentraFLOW Technology Driving Greater Adoption of the ICL Procedure MONROVIA, Calif., June 17, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has received regulatory approvals to market its Visian® Implantable Collamer® Lens (ICL(TM)) with CentraFLOW(TM) technology from the KFDA in Korea and the ANMAT in Argentina. Don Todd, President of the...

2013-05-01 16:30:57

~Total Sales of $18 Million Increased 16% from Q1 2012 / 21% Increase on Constant Currency Basis MONROVIA, Calif., May 1, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today reported record revenue for the first quarter ended March 29, 2013 of $18.0 million compared to $15.5 million reported for the first quarter of 2012. The results included sales of $10.6 million of...

2013-04-17 16:26:22

~Reviews by Key Surgeons of New CentraFLOW(TM) Technology and V5 ICL with Preloaded Delivery System MONROVIA, Calif., April 17, 2013 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced its significant participation in the upcoming annual Symposium of the American Society for Cataract and Refractive Surgery (ASCRS) to be held in San Francisco from April 19 through 23. The...